Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA
3 clinical trials · Sponsor
◉ Watch Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA
| Record | Firm | Date |
|---|---|---|
| A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease (NCT06001177) | Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA | 2023-12-13 |
| A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it) (NCT05574010) | Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA | 2022-11-15 |
| Assessment of KAN-101 in Celiac Disease (ACeD) (NCT04248855) | Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA | 2020-01-21 |
Track Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA automatically
Every clearance here is in the API, with alerts when new ones post.